AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 1 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $0 | -100.0% | 36 | -100.0% | 0.00% | -100.0% |
Q2 2020 | $584,000 | -6.3% | 76,310 | -24.3% | 0.00% | -25.0% |
Q1 2020 | $623,000 | -74.4% | 100,751 | -49.6% | 0.00% | -63.6% |
Q4 2019 | $2,431,000 | -52.4% | 199,815 | -54.8% | 0.01% | -50.0% |
Q3 2019 | $5,104,000 | -44.4% | 441,894 | -51.9% | 0.02% | -50.0% |
Q2 2019 | $9,180,000 | +4.5% | 919,064 | +34.7% | 0.04% | +15.8% |
Q1 2019 | $8,785,000 | +6.5% | 682,080 | +25.6% | 0.04% | -7.3% |
Q4 2018 | $8,247,000 | -32.3% | 542,946 | -10.8% | 0.04% | -18.0% |
Q3 2018 | $12,181,000 | +21.8% | 608,968 | +18.7% | 0.05% | +16.3% |
Q2 2018 | $10,001,000 | +168.6% | 513,013 | +177.8% | 0.04% | +168.8% |
Q1 2018 | $3,723,000 | -43.8% | 184,682 | -63.0% | 0.02% | -44.8% |
Q4 2017 | $6,621,000 | -60.0% | 499,616 | -44.4% | 0.03% | -60.3% |
Q3 2017 | $16,565,000 | -26.4% | 897,975 | -26.6% | 0.07% | -28.4% |
Q2 2017 | $22,510,000 | -18.6% | 1,223,517 | -0.3% | 0.10% | -19.7% |
Q1 2017 | $27,659,000 | +468.8% | 1,226,690 | +777.8% | 0.13% | +429.2% |
Q4 2016 | $4,863,000 | +4281.1% | 139,753 | +2991.9% | 0.02% | +2300.0% |
Q3 2016 | $111,000 | +23.3% | 4,520 | +20.8% | 0.00% | – |
Q2 2016 | $90,000 | – | 3,743 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HealthInvest Partners AB | 520,000 | $15,699,000 | 7.39% |
Palo Alto Investors LP | 2,835,792 | $85,613,000 | 4.76% |
Opaleye Management Inc. | 150,000 | $4,529,000 | 1.89% |
Engaged Capital LLC | 61,425 | $1,854,000 | 1.15% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 91,400 | $2,759,000 | 1.14% |
Endurant Capital Management LP | 111,180 | $3,357,000 | 1.12% |
AlphaOne Investment Services, LLC | 86,817 | $2,621,000 | 0.94% |
ASHFORD CAPITAL MANAGEMENT INC | 127,625 | $3,853,000 | 0.91% |
ARDSLEY ADVISORY PARTNERS LP | 205,000 | $6,189,000 | 0.81% |
STELLIAM INVESTMENT MANAGEMENT, LP | 685,000 | $20,680,000 | 0.62% |